Mouse brains deficient in neuronal PDGF receptor-beta develop normally but are vulnerable to injury

Yoko Ishii1, Takeshi Oya, Lianshun Zheng

  • 1Department of Pathology, Faculty of Medicine, University of Toyama, Toyama, Japan.

Insights

Platelet-derived growth factor receptor-beta (PDGFR-beta) in neurons protects the brain from injury. Deleting PDGFR-beta in CNS neurons exacerbates damage from cryogenic injury and NMDA excitotoxicity.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) are present in the central nervous system (CNS), but their roles are not fully understood.
  • Complete gene knockouts for PDGFRs are lethal, limiting research into their specific functions.

Purpose of the Study:

  • To investigate the function of Platelet-derived growth factor receptor-beta (PDGFR-beta) in CNS neurons, particularly during the post-natal developmental stage.
  • To elucidate the neuroprotective role of PDGFR-beta against brain injury.

Main Methods:

  • Development of novel mutant mice with genetic deletion of PDGFR-beta specifically in CNS neurons.
  • Immunohistochemical analysis to assess PDGFR-beta distribution in wild-type and mutant brains.
  • Evaluation of cerebral damage following cryogenic injury and NMDA injection in mutant and control mice.
  • TUNEL staining to quantify neuronal cell death.

Main Results:

  • Mutant mice lacking neuronal PDGFR-beta survived to adulthood with no apparent anatomical defects.
  • PDGFR-beta was significantly depleted in neurons and subventricular zone cells of mutant brains, while vascular PDGFR-beta remained unchanged.
  • Mutant mice exhibited exacerbated cerebral damage after cryogenic injury and NMDA-induced excitotoxicity, with increased neuronal cell death and lesion formation.
  • NMDA receptor expression levels were not altered in the mutant mice.

Conclusions:

  • Neuronal PDGFR-beta plays a critical role in protecting CNS neurons from cryogenic injury.
  • PDGFR-beta expressed in neurons confers protection against NMDA-induced excitotoxicity.
  • Targeting neuronal PDGFR-beta may offer therapeutic potential for neuroprotection.